Zacks Investment Research downgraded shares of MEDLEY CAPITAL (MCC) from OUTPERFORM to NEUTRAL on October 03, 2012, with a target price of $15.30.
Get all Zacks Research Reports and be alerted to fast-breaking buy and sell opportunities every trading day.
To get a free copy of the research report on MEDLEY CAPITAL (MCC),
click here.
For more information about research offerings from Zacks Investment Research, visit
Zacks.com .
Be the first to comment